Lesaffre International   Report issue

For profit Phase 4
Founded: Marcq-en-Baroeul France (1853)
Status: No NME R&D (1853)

Organization Overview

First Clinical Trial
2011
NCT00977587
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Lesaffre International

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Lesaffre International (0) Acquired (1)

chondroitin (1 trial)

Drugs in Other Trials (5)

bacillus subtilis (1 trial)

menaquinone (vitamin k2) (1 trial)

saccharomyces cerevisiae (7 trials)

yeast cell walls (1 trial)

zinc dichloride (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 10
  • # of Trial APIs: 6